Evidence map›Paper›PMID 11038184›Full record

ArticleThe Journal of cell biology2000

Targeted ablation of the murine involucrin gene.

P Djian, K Easley, H Green

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Involucrin Modulates Vitamin D Receptor Activity in the Epidermis.The Journal of investigative dermatology · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Loricrin: Past, Present, and Future.International journal of molecular sciences · 2020
    Review
  8. Article
  9. Recent evolution of the human skin barrier.Experimental dermatology · 2018
    Review
  10. Review
  11. The Molecular Revolution in Cutaneous Biology: EDC and Locus Control.The Journal of investigative dermatology · 2017
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Ancient origin of the gene encoding involucrin, a precursor of the cross-linked envelope of epidermis and related epithelia.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

P DjianCentre National de la Recherche Scientifique, UPR 2228, Régulation de la Transcription et Maladies Génétiques, Université René Descartes, 75270 Paris cedex 06, France. djian@biomedicale.univ-paris5.fr
K Easley
H Green
Harvard University · USCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Involucrin is synthesized in abundance during terminal differentiation of keratinocytes. Involucrin is a substrate for transglutaminase and one of the precursors of the cross-linked envelopes present in the corneocytes of the epidermis and other stratified squamous epithelia. These envelopes make an important contribution to the physical resistance of the epidermis. We have generated mice lacking involucrin from embryonic stem cells whose involucrin gene had been ablated by homologous recombination. These mice developed normally, possessed apparently normal epidermis and hair follicles, and made cornified envelopes that could not be distinguished from those of wild-type mice. No compensatory increase of mRNA for other envelope precursors was observed.

Indexed as

AnimalsEpidermisGene TargetingGenetic VectorsHair FollicleMiceMice, Mutant StrainsMutagenesis, Site-DirectedProtein PrecursorsReproductionSkin Physiological PhenomenainvolucrinProtein Precursors

Identifiers

PMID11038184
PMCPMC2192633
OpenAlexW2004061895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.